Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-γ in normal human T lymphocytes

Blood

Volumn 88, Issue 5, 1996, Pages 1747-1754

  Drach, Johannes ^a   Gsur, Andrea ^b   Hamilton, Gerhard ^b   Zhao, Shourong ^b   Angerler, Jutta ^b   Fiegl, Michael ^b   Zojer, Niklas ^b   Raderer, Markus ^b   Haberl, Ines ^b   Andreeff, Michael ^b   Huber, Heinz ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ; RHODAMINE 123; TAMOXIFEN; VERAPAMIL;

ADENOCARCINOMA; ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 9544240355     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1747.1747     Document Type: Article

References (49)

1. Hyde SC, Emsley P, Hartshorn M, Mimmack MM, Gileadi U, Pearce SR, Gallagher MP, Gill DR, Hubbard R, Higgins CF: Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 346:362, 1990
2. Roninson IB: Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. New York, NY, Plenum, 1991
3. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesmann MM, Pastan I: Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265, 1987
4. Thiebaut F, Tsuruo T, Hamada H, Gottesmann MM, Pastan I, Willingham MC: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7734, 1987
5. Arceci RJ, Croop JM, Horwitz SB, Housman D: The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA 85:4350, 1988
6. Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, Mori S: Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 48:1926, 1988
7. Cordon-Cardo C, O'Brien JP, Casals D, Rittman GL, Biedler JL, Melamed MR, Bertino JR: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695, 1989
8. Thiebaut F, Tsuruo T, Hamada H, Gottesmann MM, Pastan I, Willingham MC: Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 37:159, 1989
9. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR: Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38:1277, 1990
10. van der Valk P, van Kalken CK, Ketelaars H, Broxterman HJ, Scheffer G, Kuiper CM, Tsuruo T, Lankelma J, Meijer CJ, Pinedo H, Scheper R: Distribution of multidrug resistance associated P-glycoprotein in normal and neoplastic human tissues. Ann Oncol 1:56, 1990
11. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R: Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 34:24248, 1992
12. van Kalkan CK, Broxterman HJ, Pinedo HM, Feller N, Dekker H, Lankelma J, Giaccone G: Cortisol is transported by the multidrug resistance gene product P-glycoprotein. Br J Cancer 67:284, 1993
13. Neyfakh AA, Serpinskaya AS, Chervonsky AV, Apasov SG, Kazarov AR: Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection. Exp Cell Res 185:496, 1989
14. Coon JS, Wang Y, Bines SD, Markham PN, Chong ASF, Gbel HM: Multidrug resistance activity in human lymphocytes. Hum Immunol 32:134, 1991
15. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85, 1991
16. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreeff M: Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80:2729, 1992
17. Chaudhary PM, Mechetner EB, Roninson IB: Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735, 1992
18. Marie JP, Brophy NA, Ehsan MN, Aihara Y, Mohamed NA, Cornbleet J, Chao NJ, Sikic BI: Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells. Br J Haematol 81:145, 1992
19. Gupta S, Kim CH, Tsuruo T, Gollapudi S: Preferential expression of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: A role in cytotoxic effector function. J Clin Immunol 12:451, 1992
20. Klimecki WT, Futscher BW, Grogan TM, Dalton WS: P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451, 1994
21. Witkowski JM, Li SP, Gorgas G, Miller RA: Extrusion of the P glycoprotein substrate rhodamine-123 distinguishes CD4 memory T cell subsets that differ in IL-2-driven IL-4 production. J Immunol 153:658, 1994
22. Drach J, Zhao S, Drach D, Körbling M, Engel H, Andreeff M: Expression of 1 by normal bone marrow cells and its implication for leukemic hematopoiesis. Leuk Lymphoma 16:419, 1995
23. Chong AS-F, Markham PN, Gebel HM, Bines SD, Coon JS: Diverse multidrug-resistance modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother 36:133, 1993
24. McGrath T, Varshavsky A: The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature 340:400. 1989
25. Raymond M, Gros P, Whiteway M, Thomas DY: Functional complementation of yeast ste6 by a mammalian multidrug-resistance mdr gene. Science 256:232, 1992
26. Scharma RC, Inoue S, Roitelman J, Schimke RT, Simoni RD: Peptide transport by the multidrug resistance pump. J Biol Chem 267:5731, 1992
27. Cornwell MM, Safa A, Felsted RL, Gottesmann MM, Pastan I: Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc Natl Acad Sci USA 83:3847, 1986
28. Safa AR: Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. Proc Natl Acad Sci USA 85:7187, 1988
29. Yusa K, Tsuruo T: Reversal mechanism of multidrug resistance by verapamil: Direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res 49:5002, 1989
30. Berman E, Adams M, Duigou-Osterndorf R, Godfrey L, Clarkson B, Andreeff M: Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype. Blood 77:818, 1991
31. Foxwell BMJ, Mackie A, Ling V, Ryffel B: Identification of the multidrug related P-glycoprotein as a cyclosporin binding protein. Mol Pharmacol 36:543, 1989
32. Tamai I, Safa A: Competitive interaction of cyclosporins with vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells. J Biol Chem 266:16509, 1990
33. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T: Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 268:6077, 1993
34. Mechetner EB, Roninson IB: Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci USA 89:5824, 1992
35. Hamada H, Tsuruo T: Functional role for the 170-180 kDa glycoprotein specific to drug resistant tumor cells as treated by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785, 1986
36. Chomcyznki P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
37. Hunter J, Hirst BH, Simmons NL: Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein. Br J Cancer 64:437, 1991
38. Zacherl J, Hamilton G, Thalhammer T, Riegler M, Cosentini EP, Ellinger A, Bischof G, Schweitzer M, Teleky B, Kopema T, Wenzl E: Inhibition of P-glycoprotein mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence of extracellular pH. Cancer Chemother Pharmacol 34:125, 1994
39. Elliott JF, Lin Y, Mizel SB, Bleackly RC, Harnish DG, Paetkau V: Induction of interleukin-2 messenger RNA inhibited by cyclosporin A. Science 226:1439, 1984
40. Hughson EJ, Hopkins CR: Endocytic pathways in polarized Caco-2 cells: identification of an endosomal compartment accessible from both apical and basolateral surfaces. J Cell Biol 110:337, 1990
41. March CJ, Mosley B, Larsen A, Cerreti DP, Braedt G, Price V, Gillis S, Henney CS. Kronheim SR, Grabstein K, Conlon PJ, Hopp TP, Cosman D: Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641, 1985
42. Singer II, Scott S, Hall GI, Limjuco G, Chin J, Schmidt JA: Interleukin-1 beta is localized in the cytoplasmic ground substance but is largely absent from the golgi apparatus and plasma membranes of stimulated human monocytes. J Exp Med 167:389, 1988
43. Young PR, Krasney PA: Stimulation of interleukin-1 beta secretion in monkey kidney cells by coexpression of the mammalian P-glycoprotein 1, in Ghezzi P, Mantovani A (eds): Pathophysiology and Pharmacology of Cytokines. Biomedical, 1992, p 21
44. Raghu G, Park SW, Roninson IB, Mechetner EB: P-glycoprotein transports interleukin-2 in human T-lymphocytes. (submitted for publication)
45. Bommhardt U, Cerottini J-C, MacDonald HR: Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function. Eur J Immunol 24:2974, 1994
46. Hardy SP, Goodfellow HR, Valverde MA, Gill DR, Sepulveda V, Higgins CF: Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J 14:68, 1995
47. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G, Cantiello HF: The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA 90:312, 1993
48. Gosland MP, Brophy NA, Duran GE, Yahanda AM, Adler KM, Hardy RI, Halsey J, Sikic BI: Bilirubin - A physiologic substrate for the multidrug transporter. Proc Am Assoc Cancer Res 32:426a, 1991
49. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P: Absence of the mdrla P-glycoprotein in mice affects tissue distribution and pharmakokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698, 1995